News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Encore Therapeutics Inc. Reports Efficacy Data On A Long-Acting Local Anesthetic Drug



1/30/2007 12:26:05 PM

CARLSBAD, Calif.--(BUSINESS WIRE)--Encore Therapeutics Inc. (ETI) today reported results of two pre-clinical efficacy studies demonstrating that its extended release Ropivicaine (ETI-211) can provide anesthetic action for 3 days. ETI-211 is designed for post-surgical pain management; to reduce opiate use and possibly shorten hospital stays.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES